BIOGEN INC. Other Revenue, Net (Deprecated 2018-01-31)
BIOGEN INC. (BIIB) reported Other Revenue, Net (Deprecated 2018-01-31) of $164.40 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-24.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2018-04-24
- BIOGEN INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $164.40M, a 82.67% increase year-over-year.
- BIOGEN INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $179.60M, a 252.85% increase year-over-year.
- BIOGEN INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $48.80M, a 50.51% decline year-over-year.
- BIOGEN INC. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $41.60M, a 47.34% decline year-over-year.
- BIOGEN INC. other revenue, net (deprecated 2018-01-31) for fiscal 2017 was $360.00M, a 13.78% increase from fiscal 2016.
- BIOGEN INC. other revenue, net (deprecated 2018-01-31) for fiscal 2016 was $316.40M, a 34.01% increase from fiscal 2015.
- BIOGEN INC. other revenue, net (deprecated 2018-01-31) for fiscal 2015 was $236.10M, a 22.46% decline from fiscal 2014.
- BIOGEN INC. other revenue, net (deprecated 2018-01-31) for fiscal 2014 was $304.50M, a 15.38% increase from fiscal 2013.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 9 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 12 month | Other Revenue, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $164.40M 10-Q · filed 2018-04-24 | $344.00M derived: sum of 2 quarters · filed 2018-04-24 | $392.80M derived: sum of 3 quarters · filed 2018-04-24 | $434.40M derived: sum of 4 quarters · filed 2018-04-24 | ||||
| 2017-12-31 | $179.60M 10-K · filed 2018-02-01 | $228.40M derived: sum of 2 quarters · filed 2018-02-01 | $270.00M derived: sum of 3 quarters · filed 2018-02-01 | $360.00M 10-K · filed 2018-02-01 | ||||
| 2017-09-30 | $48.80M 10-K · filed 2018-02-01 | $90.40M derived: sum of 2 quarters · filed 2018-02-01 | $180.40M 10-Q · filed 2017-10-24 | $231.30M derived: sum of 4 quarters · filed 2018-04-24 | ||||
| 2017-06-30 | $41.60M 10-K · filed 2018-02-01 | $131.60M 10-Q · filed 2017-07-25 | $182.50M derived: sum of 3 quarters · filed 2018-04-24 | $281.10M derived: sum of 4 quarters · filed 2018-04-24 | ||||
| 2017-03-31 | $90.00M 10-Q · filed 2018-04-24 | $140.90M derived: sum of 2 quarters · filed 2018-04-24 | $239.50M derived: sum of 3 quarters · filed 2018-04-24 | $318.50M derived: sum of 4 quarters · filed 2018-04-24 | ||||
| 2016-12-31 | $50.90M 10-K · filed 2018-02-01 | $149.50M derived: sum of 2 quarters · filed 2018-02-01 | $228.50M derived: sum of 3 quarters · filed 2018-02-01 | $316.40M 10-K · filed 2018-02-01 | ||||
| 2016-09-30 | $98.60M 10-K · filed 2018-02-01 | $177.60M derived: sum of 2 quarters · filed 2018-02-01 | $265.50M 10-Q · filed 2017-10-24 | $345.00M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $79.00M 10-K · filed 2018-02-01 | $166.90M 10-Q · filed 2017-07-25 | $246.40M derived: sum of 3 quarters · filed 2018-02-01 | $295.40M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $87.90M 10-K · filed 2018-02-01 | $167.40M derived: sum of 2 quarters · filed 2018-02-01 | $216.40M derived: sum of 3 quarters · filed 2018-02-01 | $272.00M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $79.50M 10-K · filed 2017-02-02 | $128.50M derived: sum of 2 quarters · filed 2017-02-02 | $184.10M derived: sum of 3 quarters · filed 2017-02-02 | $236.10M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $49.00M 10-K · filed 2017-02-02 | $48.96M 10-Q · filed 2015-10-21 | $104.60M derived: sum of 2 quarters · filed 2017-02-02 | $156.60M 10-Q · filed 2016-10-26 | $156.56M 10-Q · filed 2015-10-21 | $205.80M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-06-30 | $55.60M 10-K · filed 2017-02-02 | $55.57M 10-Q · filed 2015-07-24 | $107.60M 10-Q · filed 2016-07-21 | $107.60M 10-Q · filed 2015-07-24 | $156.80M derived: sum of 3 quarters · filed 2017-02-02 | $260.20M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-03-31 | $52.00M 10-K · filed 2017-02-02 | $52.03M 10-Q · filed 2015-04-24 | $101.20M derived: sum of 2 quarters · filed 2017-02-02 | $204.60M derived: sum of 3 quarters · filed 2017-02-02 | $266.50M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $49.20M 10-K · filed 2016-02-03 | $152.60M derived: sum of 2 quarters · filed 2016-02-03 | $214.50M derived: sum of 3 quarters · filed 2016-02-03 | $304.50M 10-K · filed 2017-02-02 | $304.53M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $103.40M 10-K · filed 2016-02-03 | $103.40M 10-Q · filed 2014-10-22 | $165.30M derived: sum of 2 quarters · filed 2016-02-03 | $255.37M 10-Q · filed 2015-10-21 | $344.80M derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2014-06-30 | $61.90M 10-K · filed 2016-02-03 | $61.86M 10-Q · filed 2014-07-23 | $151.97M 10-Q · filed 2015-07-24 | $241.40M derived: sum of 3 quarters · filed 2016-02-03 | $312.40M derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2014-03-31 | $90.10M 10-K · filed 2016-02-03 | $90.10M 10-Q · filed 2014-04-23 | $179.50M derived: sum of 2 quarters · filed 2016-02-03 | $250.50M derived: sum of 3 quarters · filed 2016-02-03 | $299.30M derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2013-12-31 | $89.40M 10-K · filed 2015-02-04 | $160.40M derived: sum of 2 quarters · filed 2015-02-04 | $209.20M derived: sum of 3 quarters · filed 2015-02-04 | $263.90M 10-K · filed 2016-02-03 | $263.85M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $71.00M 10-K · filed 2015-02-04 | $71.02M 10-Q · filed 2013-10-28 | $119.80M derived: sum of 2 quarters · filed 2015-02-04 | $174.50M 10-Q · filed 2014-10-22 | $236.80M derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2013-06-30 | $48.80M 10-K · filed 2015-02-04 | $48.77M 10-Q · filed 2013-07-25 | $103.48M 10-Q · filed 2014-07-23 | $165.80M derived: sum of 3 quarters · filed 2015-02-04 | $224.40M derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2013-03-31 | $54.70M 10-K · filed 2015-02-04 | $54.71M 10-Q · filed 2013-04-25 | $117.00M derived: sum of 2 quarters · filed 2015-02-04 | $175.60M derived: sum of 3 quarters · filed 2015-02-04 | $235.20M derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2012-12-31 | $62.30M 10-K · filed 2014-02-06 | $120.90M derived: sum of 2 quarters · filed 2014-02-06 | $180.50M derived: sum of 3 quarters · filed 2014-02-06 | $212.46M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $58.60M 10-K · filed 2014-02-06 | $58.65M 10-Q · filed 2012-10-25 | $118.20M derived: sum of 2 quarters · filed 2014-02-06 | $150.15M 10-Q · filed 2013-10-28 | $222.80M derived: sum of 4 quarters · filed 2014-02-06 | |||
| 2012-06-30 | $59.60M 10-K · filed 2014-02-06 | $59.52M 10-Q · filed 2012-07-24 | $91.50M 10-Q · filed 2013-07-25 | $164.20M derived: sum of 3 quarters · filed 2014-02-06 | $231.90M derived: sum of 4 quarters · filed 2014-02-06 | |||
| 2012-03-31 | $32.00M 10-K · filed 2014-02-06 | $31.97M 10-Q · filed 2012-05-01 | $104.60M derived: sum of 2 quarters · filed 2014-02-06 | $172.30M derived: sum of 3 quarters · filed 2014-02-06 | $207.80M derived: sum of 4 quarters · filed 2014-02-06 | |||
| 2011-12-31 | $72.60M 10-K · filed 2013-02-05 | $140.30M derived: sum of 2 quarters · filed 2013-02-05 | $175.80M derived: sum of 3 quarters · filed 2013-02-05 | $215.92M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $67.70M 10-K · filed 2013-02-05 | $67.71M 10-Q · filed 2011-10-28 | $103.20M derived: sum of 2 quarters · filed 2013-02-05 | $143.31M 10-Q · filed 2012-10-25 | $194.70M derived: sum of 4 quarters · filed 2013-02-05 | |||
| 2011-06-30 | $35.50M 10-K · filed 2013-02-05 | $35.49M 10-Q · filed 2011-07-26 | $75.60M 10-Q · filed 2012-07-24 | $127.00M derived: sum of 3 quarters · filed 2013-02-05 | $168.00M derived: sum of 4 quarters · filed 2013-02-05 | |||
| 2011-03-31 | $40.10M 10-K · filed 2013-02-05 | $40.12M 10-Q · filed 2011-04-21 | $91.50M derived: sum of 2 quarters · filed 2013-02-05 | $132.50M derived: sum of 3 quarters · filed 2013-02-05 | $179.60M derived: sum of 4 quarters · filed 2013-02-05 | |||
| 2010-12-31 | $51.40M 10-K · filed 2012-02-03 | $92.40M derived: sum of 2 quarters · filed 2012-02-03 | $139.50M derived: sum of 3 quarters · filed 2012-02-03 | $169.12M 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | $41.00M 10-K · filed 2012-02-03 | $40.96M 10-Q · filed 2010-10-26 | $88.10M derived: sum of 2 quarters · filed 2012-02-03 | $117.77M 10-Q · filed 2011-10-28 | $161.40M derived: sum of 4 quarters · filed 2012-02-03 | |||
| 2010-06-30 | $47.10M 10-K · filed 2012-02-03 | $47.10M 10-Q · filed 2010-07-20 | $76.81M 10-Q · filed 2011-07-26 | $120.40M derived: sum of 3 quarters · filed 2012-02-03 | $155.30M derived: sum of 4 quarters · filed 2012-02-03 | |||
| 2010-03-31 | $29.70M 10-K · filed 2012-02-03 | $29.71M 10-Q · filed 2010-04-20 | $73.30M derived: sum of 2 quarters · filed 2012-02-03 | $108.20M derived: sum of 3 quarters · filed 2012-02-03 | $134.90M derived: sum of 4 quarters · filed 2012-02-03 | |||
| 2009-12-31 | $43.60M 10-K · filed 2011-02-04 | $78.50M derived: sum of 2 quarters · filed 2011-02-04 | $105.20M derived: sum of 3 quarters · filed 2011-02-04 | $129.54M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | $34.90M 10-K · filed 2011-02-04 | $34.91M 10-Q · filed 2009-10-21 | $61.60M derived: sum of 2 quarters · filed 2011-02-04 | $85.92M 10-Q · filed 2010-10-26 | $119.76M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-06-30 | $26.70M 10-K · filed 2011-02-04 | $26.75M 10-Q · filed 2009-07-17 | $51.01M 10-Q · filed 2010-07-20 | $84.86M derived: sum of 3 quarters · filed 2011-02-04 | $120.59M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-03-31 | $24.30M 10-K · filed 2011-02-04 | $24.26M 10-Q · filed 2010-04-20 | $58.16M derived: sum of 2 quarters · filed 2011-02-04 | $93.89M derived: sum of 3 quarters · filed 2011-02-04 | $124.03M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2008-12-31 | $33.86M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $69.59M derived: sum of 2 quarters · filed 2011-02-04 | $99.72M derived: sum of 3 quarters · filed 2011-02-04 | $129.62M 10-K · filed 2011-02-04 | ||||
| 2008-09-30 | $35.73M 10-Q · filed 2009-10-21 | $65.86M derived: sum of 2 quarters · filed 2009-10-21 | $95.75M 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | $30.14M 10-Q · filed 2009-07-17 | $60.03M 10-Q · filed 2009-07-17 | ||||||
| 2007-12-31 | $108.70M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |